search icon

    Market Snapshot

    • S&P Futures

      3,814.5

    • Dow Futures

      30,961

    • Nasdaq Futures

      11,557.75

    blog search icon

    PDS Biotechnology Corporation

    (NASDAQ:PDSB)

    $3.69

    $0.04

    1.10%

    PDS Biotechnology Corporation Chart

    PDSB Stock Price Today

    PDS Biotechnology Corporation (PDSB) stock rallied over 1.10% intraday to trade at $3.69 a share on NASDAQ. The stock opened with a loss of -0.54% at $3.66 and touched an intraday high of $3.83, rising 1.10% against the last close of $3.65. The stock went to a low of $3.56 during the session.

    Stock Snapshot

    $3.65

    Prev. Close

    103.8 Million

    Market Cap

    $3.56

    Day Low

    $3.66

    Open

    26.16 Million

    Number of Shares

    $3.83

    Day High

    -

    P/E ratio

    -0.82

    EPS (TTM)

    2.29

    Cash Flow per Share

    7.97

    Free Float in %

    2.39

    Book Value

    341,891

    Volume

    PDS Biotechnology Corporation Historical Data

    DateOpenHighLowCloseVolume
    2022-07-01$3.66$3.83$3.56$3.69341,900
    2022-06-30$3.71$3.75$3.625$3.65142,700
    2022-06-29$3.87$3.89$3.67$3.78177,100
    2022-06-28$3.95$4.07$3.81$3.9231,200
    2022-06-27$3.79$4.07$3.68$3.93264,100
    2022-06-24$3.74$3.85$3.68$3.75375,000
    2022-06-23$3.58$3.73$3.551$3.7264,200
    2022-06-22$3.41$3.67$3.41$3.54232,700
    2022-06-21$3.47$3.681$3.45$3.46322,300
    2022-06-17$3.15$3.45$3.09$3.35436,900

    Contact Details

    25B Vreeland Road
    Florham Park, NJ 07932
    United States

    Webiste:PDSB

    800 208 3343

    Company Information

    Employees-

    Beta2.27

    Sales or Revenue0

    5Y Sales Change-

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.

    Frequently Asked Questions

    icon

    What is the current PDS Biotechnology Corporation (PDSB) stock price?

    PDS Biotechnology Corporation (NASDAQ: PDSB) stock price is $3.69 as of the last check on Friday, July 1. During the trading session, PDSB stock reached the peak price of $3.83 while $3.56 was the lowest point it dropped to.

    icon

    PDSB's industry and sector of operation?

    The NASDAQ listed PDSB is part of Biotechnology industry that operates in the broader Health Care sector. PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer.

    icon

    Who are the executives of PDSB?

    Ms. Hillary Yegen
    VP of Legal
    Dr. Frank K. Bedu-Addo Ph.D.
    Pres, CEO & Director
    Dr. Gregory L. Conn
    Chief Scientific Officer
    Ms. Lauren V. Wood M.D.
    Chief Medical Officer

    icon

    What is the PDSB stock price today?

    PDSB stock traded closed the last session at $3.69, which is $0.04 or 1.10% lower than its previous close of $3.65. PDSB's current trading price is 26.80% lower than its 52-week high of $17.85 where as its distance from 52-week low of 2.91% is -79.33%.

    icon

    How many employees does PDSB have?

    Number of PDSB employees currently stands at -. PDSB operates from 25B Vreeland Road, Florham Park, NJ 07932, United States.

    icon

    Link for PDSB official website?

    Official Webiste of $PDSB is: https://www.pdsbiotech.com

    icon

    How do I contact PDSB?

    PDSB could be contacted at PDSB operates from 25B Vreeland Road, Florham Park, NJ 07932, United States, or at phone #800 208 3343 and can also be accessed through its website.

    icon

    How many shares of PDSB are traded daily?

    PDSB stock volume for the day was 341,891 shares while in the previous session number of PDSB shares traded was 341,900 . The average number of PDSB shares traded daily for last 3 months was 648.96 Thousands.

    icon

    How much did PDSB change today?

    The percentage change in PDSB stock occurred in the recent session was 1.10% while the dollar amount for the price change in PDSB stock was $0.04.

    icon

    What price range PDSB stock been trading in?

    In the recent session, the day high for PDSB stock was $3.83 while the low for PDSB stock touched on the day was $3.56.

    icon

    What is the market cap of PDSB currently?

    The market value of PDSB currently stands at 103.8 Million with its latest stock price at $3.69 and 26.16 Million of its shares outstanding.